Mesa Laboratories
MLAB
175 hedge funds and large institutions have $1B invested in Mesa Laboratories in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 69 increasing their positions, 55 reducing their positions, and 15 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 55
20% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 15
0.59% more ownership
Funds ownership: 92.56% → 93.15% (+0.59%)
0% more funds holding
Funds holding: 175 → 175 (0)
19% less capital invested
Capital invested by funds: $1.24B → $1B (-$237M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
+$7.86M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$7.4M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$3.41M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2.64M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$2.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$17.3M |
| 2 |
BlackRock
New York
|
-$8.92M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.24M |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$1.37M |
| 5 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$1.25M |
MLAB Hedge Fund Activity: Q2 2022 in Review
175 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q2 2022, worth a combined $1B — down 19% from $1.24B a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new MLAB positions and 15 closed out — a net gain of 3 holders — while 69 added to existing stakes and 55 trimmed.
The largest buyer was Atlanta Capital Management, adding an estimated $7.86M. The largest seller was Royce & Associates, cutting an estimated $17.3M.
- 175 institutional investors held Mesa Laboratories (MLAB) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $1B of Mesa Laboratories stock for Q2 2022, down 19% quarter-over-quarter.
- 18 funds opened new Mesa Laboratories positions in Q2 2022 and 15 closed out, a net change of +3 holders.
- The largest Mesa Laboratories buyer in Q2 2022 was Atlanta Capital Management, an estimated $7.86M added.
- The largest Mesa Laboratories seller in Q2 2022 was Royce & Associates, an estimated $17.3M sold.
Based on aggregated 13F filings for Q2 2022.